Skip to main content
TipRanks
Go Ultimate75% OFF

Sutro Biopharma (S090) Ownership - Who Owns Sutro Biopharma?

1 Followers

Sutro Biopharma (S090) Ownership Overview

  • 0.73% Insiders
  • 15.65% Mutual Funds
  • 60.75% Other Institutional Investors
  • 10.09% ETFs
  • 12.78% Public Companies and Individual Investors

The ownership structure of Sutro Biopharma (DE:S090) stock is a mix of institutional, retail, and individual investors. Approximately 86.49% of the company’s stock is owned by Institutional Investors, 0.73% is owned by Insiders, and 12.78% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:S090 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.1,178,196Institution7.10%14,895,932
Joseph Edelman970,846Institution5.85%12,274,406
Vanguard733,928Institution4.42%9,279,052
Vanguard Index Funds678,732Institution4.09%8,581,209
Ishares626,092Institution3.77%7,915,681
Mutual Fund Series Trust585,262Institution3.53%7,399,467
Tiaa-cref Funds355,782Institution2.14%4,498,152
Michael Rockefeller350,136Institution2.11%4,426,769
Peter Kolchinsky210,934Institution1.27%2,666,839
Fidelity Salem Street Trust194,886Institution1.17%2,463,944

Top Mutual Fund Holders

DE:S090 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds678,732Institution4.09%8,581,209
Mutual Fund Series Trust585,262Institution3.53%7,399,467
Tiaa-cref Funds355,782Institution2.14%4,498,152
Fidelity Salem Street Trust194,886Institution1.17%2,463,944
Goldman Sachs Trust157,201Institution0.95%1,987,492
Fidelity Concord Street Trust113,672Institution0.68%1,437,155
Vanguard Scottsdale Funds107,894Institution0.65%1,364,104
Schwab Capital Trust77,471Institution0.47%979,466
Jpmorgan Trust I60,304Institution0.36%762,423
Fidelity Commonwealth Trust Ii49,542Institution0.30%626,360

FAQ

Who Owns Sutro Biopharma (DE:S090)?
According to the latest TipRanks data, approximately 86.49% of the company's stock is held by institutional investors, 0.73% is held by insiders, and 12.78% is held by public companies and individual investors.
What percentage of Sutro Biopharma (DE:S090) stock is held by institutional investors?
According to the latest TipRanks data, approximately 86.49% of Sutro Biopharma (DE:S090) stock is held by institutional investors: 15.65% by mutual funds, 10.09% by ETFs and 60.75% by other institutional investors.
What percentage of Sutro Biopharma (DE:S090) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.78% of Sutro Biopharma (DE:S090) stock is held by public companies and individual investors.
Who owns the most shares of Sutro Biopharma (DE:S090)?
BlackRock, Inc. owns the most shares of Sutro Biopharma (DE:S090).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.